Condition
Aneurysmal Subarachnoid Haemorrhage
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Recruiting1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04356599Not ApplicableCompletedPrimary
Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Using Dynamic 18F-FDG PET/CT
NCT06804421RecruitingPrimary
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT05259514Not ApplicableTerminatedPrimary
CytoSorb SAH Trial
NCT01832389Not ApplicableCompletedPrimary
Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage
NCT01801800CompletedPrimary
Cardiac Function in Severe Aneurysmal Subarachnoid Haemorrhage Patients
Showing all 5 trials